Does CAPMATINIB Cause Metastases to bone? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Metastases to bone have been filed in association with CAPMATINIB (TABRECTA). This represents 0.6% of all adverse event reports for CAPMATINIB.
14
Reports of Metastases to bone with CAPMATINIB
0.6%
of all CAPMATINIB reports
5
Deaths
2
Hospitalizations
How Dangerous Is Metastases to bone From CAPMATINIB?
Of the 14 reports, 5 (35.7%) resulted in death, 2 (14.3%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPMATINIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which CAPMATINIB Alternatives Have Lower Metastases to bone Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN